Estrogen therapy promising for women with treatment-resistant schizophrenia

Source: alasbimn journal

Professor Jayashri Kulkarni and a team of researchers at the Monash Alfred Psychiatry research centre have published evidence in the journal Molecular Psychiatry, showing the clinical effectiveness of estrogen as an adjunct therapy for women with treatment-resistant schizophrenia. Their large-scale trial adds to the growing body of evidence that estradiol has antipsychotic effects, particularly at higher doses, and has a clinically meaningful effect in this particular group of women. See article reference and abstract.